Índice

• • ·Applications of FDG-PET in Central Nervous System Disorders

    Página :i

    Andrew B. Newberg, Eric Guedj, Abass Alavi

    
• • ·Copyright

    Página :ii

    
• • ·Contributors

    Página :iii

    Esquema Esquema
• • ·Contents

    Página :v

    Esquema Esquema
• • ·Forthcoming Issues

    Página :ix

    Esquema Esquema
• • ·CME Accreditation Page

    Página :xi

    
• • ·Five Decades of Unparalleled Impact of Fluorodeoxyglucose-PET on Day-to-Day Practice of Medicine

    Página :xiii

    Abass Alavi

    
• • ·Five Decades of [18F]Fluorodeoxyglucose–PET in Neuropsychiatric Disorders: From Brain Metabolism to Precision Functional Imaging

    Página :xv

    Andrew B. Newberg, Eric Guedj, Abass Alavi

     
• • ·18F-Fluorodeoxyglucose PET, the Brain, and Other Organs : From the First Human Studies (1976) to 2026

    Página :459-470

    Abass Alavi, Mona-Elisabeth Revheim, Andrew B. Newberg, Thomas J. Werner, Eric Guedj

    Resumen Resumen Esquema Esquema  
• • ·Normal Patterns and Variants in PET Brain Imaging from Childhood to Aging

    Página :471-482

    Sahar Darabi Monadi, Thomas J. Werner, Abass Alavi, Andrew B. Newberg

    Resumen Resumen Esquema Esquema  
• • ·FDG-PET in Cognitive Impairment and Dementia

    Página :483-497

    Julie Hong, Daniel H.S. Silverman

    Resumen Resumen Esquema Esquema  
• • ·FDG-PET in Movement Disorders and Parkinsonian Syndromes

    Página :499-509

    Satoshi Minoshima, Thilo van Eimeren, Alexander Drzezga

    Resumen Resumen Esquema Esquema  
• • ·2-[¹⁸F]fluoro-2-deoxy-d-glucose PET in Brain Tumors

    Página :511-520

    Camille Steenhout, Roland Hustinx, Andrew B. Newberg, Abass Alavi, Nadia Withofs

    Resumen Resumen Esquema Esquema  
• • ·FDG-PET in Traumatic Brain Injury and Postconcussive Sequelae

    Página :521-531

    Rizwan Naseer, Melika Mirbod, Yousr Hassan, Abass Alavi, Cyrus Ayubcha

    Resumen Resumen Esquema Esquema  
• • ·Brain [18F]FDG-PET in Encephalitis and Postinfectious Neurocognitive Syndromes

    Página :533-540

    Eric Guedj, Tatiana Horowitz, Antoine Verger

    Resumen Resumen Esquema Esquema  
• • ·¹⁸F-fluorodeoxyglucose PET in Major Psychiatric Disorders

    Página :541-552

    Rodolfo Ferrando, Artur Martins Coutinho

    Resumen Resumen Esquema Esquema  
• • ·Brain [18F]FDG-PET in Subjective Cognitive Complaints : From Diagnostic Gap to Neurobiological Insight

    Página :553-560

    Eric Guedj, Antoine Verger, Tatiana Horowitz

    Resumen Resumen Esquema Esquema
• • ·Fluorodeoxyglucose PET and Consciousness

    Página :561-571

    Cyrus Ayubcha, Thomas J. Werner, Abass Alavi, Andrew B. Newberg

    Resumen Resumen Esquema Esquema  
• • ·Fluorodeoxyglucose PET Scans in the Integrative Medicine Setting

    Página :573-585

    Andrew B. Newberg, Yining Hua, Cyrus Ayubcha, Daniel A. Monti

    Resumen Resumen Esquema Esquema  
• • ·How Fluorine-18-labeled Fluorodeoxyglucose PET Changed Clinical Practice in Central Nervous System Disorders

    Página :587-592

    Eric Guedj, Andrew B. Newberg, Abass Alavi

    Resumen Resumen Esquema Esquema
• • ·Future Directions for [18F]FDG PET in Central Nervous System Diseases

    Página :593-597

    Eric Guedj, Andrew B. Newberg, Abass Alavi

    Resumen Resumen Esquema Esquema